PKCα mediated induction of miR-101 in human hepatoma HepG2 cells

被引:43
|
作者
Chiang, Chao-Wei [1 ]
Huang, Yi [2 ]
Leong, Ka-Wai [2 ]
Chen, Lih-Chyang [3 ]
Chen, Hua-Chien [4 ]
Chen, Shu-Jen [4 ]
Chou, Chen-Kung [1 ,2 ]
机构
[1] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan
[2] Chang Gung Univ, Grad Inst Basic Med Sci, Dept Life Sci, Tao Yuan, Taiwan
[3] Chang Gung Univ, Chang Gung Mol Med Res Ctr, Tao Yuan, Taiwan
[4] Chang Gung Univ, Mol Med Res Ctr, Genom Core Lab, Tao Yuan, Taiwan
关键词
PROTEIN-KINASE-C; HEPATOCELLULAR-CARCINOMA; GROWTH-INHIBITION; EPITHELIAL-CELLS; TUMOR-SUPPRESSOR; CANCER; MICRORNA-101; ACTIVATION; EXPRESSION; MECHANISM;
D O I
10.1186/1423-0127-17-35
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Protein Kinase C (PKC) is a serine/threonine kinase that involved in controlling of many cellular processes such as cell proliferation and differentiation. We have observed previously that TPA (12-O-tetradecanoylphorbol 13-acetate) induces cell cycle arrest in G0/G1 phase in human hepatoma HepG2 cells. However, is there any miRNA involved in PKCa mediated cell growth arrest is still unknown. Methods: We first surveyed 270 miRNA expression profiles in 20 pairs of human hepatoma tissues. We identified 11 up-regulated and 23 down-regulated miRNAs (FDR < = 0.01; fold-change > = 2) in human hepatoma tissue after Student's T-test and Mann-Whitney rank test. We then examined miRNAs expression profile in TPA treated HepG2 cells. Two miRNAs, miR-101, and miR-29c, were shown to be significantly down regulated in human hepatoma tissues and induced over 4-fold in HepG2 cells under TPA treatment. Results: In this study, we examined TPA regulated miRNA expression profile in human hepatoma HepG2 cells. We identified two miRNAs, 101 and 29c, were induced by TPA and down regulated in human hepatoma tissues suggest that they might play as tumor suppressor gene and in tumor formation of HCC. Since induction kinetics of miR-101 by TPA was much faster than miR-29c suggests that the induction of miR-101 may be the primary response of TPA treatment. We then further investigated how miR-101 was regulated by TPA. MiR-101 targets two subunits of PRC2 complex, enhancer of zeste homolog 2 (EZH2) and EED, and was shown to play as a tumor suppressor gene in human prostate, breast and liver cancers. The target sequence of miR-101 located in the 3' UTR of both EZH2 and EED's mRNA was identified by bioinformatic analysis and was validated by reporter luciferase activity assay. Then we showed that TPA not only up regulated miR-101 expression, but also reduced protein level of EZH2, EED and H3K27me3 in HepG2 cells. Using lenti-virus-mediated shRNA to knockdown endogenous PKCa expression, we observed that TPA induced growth arrest, elevation of miR-101 and reduction of EZH2, EED and H3K27me3 proteins were all PKCa dependent. Specific inhibitor of ERK completely blocked TPA induced miR-101 expression. Conclusions: Therefore, this is the first time to show that PKCa and ERK pathway play important role to activate miR-101 expression, reduce PRC2 complex and H3K27me3 level. This epigenetic regulatory pathway may represent a novel mechanism of carcinogenesis and deserve further investigation.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Celastrol Induces Autophagy by Targeting AR/miR-101 in Prostate Cancer Cells
    Guo, Jianquan
    Huang, Xuemei
    Wang, Hui
    Yang, Huanjie
    PLOS ONE, 2015, 10 (10):
  • [32] miR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2
    Lei, Qiong
    Shen, Fengmei
    Wu, Jie
    Zhang, Weishan
    Wang, Jiahui
    Zhang, Lin
    ONCOLOGY REPORTS, 2014, 32 (01) : 261 - 269
  • [33] A novel AP-1/miR-101 regulatory feedback loop and its implication in the migration and invasion of hepatoma cells
    Liu, Jing-Jing
    Lin, Xue-Jia
    Yang, Xiao-Jing
    Zhou, Liangji
    He, Shuai
    Zhuang, Shi-Mei
    Yang, Jine
    NUCLEIC ACIDS RESEARCH, 2014, 42 (19) : 12041 - 12051
  • [34] Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells
    Lu, Cai-Jie
    He, Yi-Feng
    Yuan, Wei-Zhuang
    Xiang, Li-Jun
    Zhang, Jian
    Liang, Yan-Rui
    Duan, Juan
    He, Yun-He
    Li, Ming-Yi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (34) : 6242 - 6251
  • [35] Antiproliferative and apoptotic effects of strychnine in human hepatoma HepG2 cells and its mechanism
    Liu, Ruoxuan
    Ouyang, Jie
    Gao, Yinyi
    Wang, Bingyu
    Li, Liming
    Geng, Yi
    Guo, Jiewen
    MATERIALS EXPRESS, 2023, 13 (04) : 598 - 604
  • [36] In Vitro Toxicity of Silver Nanoparticles at Noncytotoxic Doses to HepG2 Human Hepatoma Cells
    Kawata, Koji
    Osawa, Masato
    Okabe, Satoshi
    ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2009, 43 (15) : 6046 - 6051
  • [37] EFFECT OF EMODIN COMBINED WITH CISPLATIN ON THE INVASION AND MIGRATION OF HEPG2 HEPATOMA CELLS
    Yang, M.
    Xiong, Z.
    Deng, H.
    Chen, X.
    Lai, Q.
    Wang, H.
    Leng, Y.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2023, 74 (04): : 403 - 411
  • [38] Investigation on the Human Hepatoma HEPG2 Cells Adhesion under the Synergy of Stiffness and Superhydrophobicity
    Li, Hao
    Qi, Wenqian
    Song, Wenlong
    COLLOID AND INTERFACE SCIENCE COMMUNICATIONS, 2018, 22 : 49 - 53
  • [39] Cytotoxicity and apoptosis induced by a new podophyllotoxin glucoside in human hepatoma (HepG2) cells
    Liu, Yanfeng
    Zhao, Changqi
    Li, Hongxing
    Yu, Miao
    Gao, Jiali
    Wang, Lei
    Zhai, Yonggong
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2010, 88 (04) : 472 - 479
  • [40] Killing Effects of Different Physical Factors on Extracorporeal HepG2 Human Hepatoma Cells
    Zhang, Kun-Song
    Zhou, Qi
    Wang, Ya-Feng
    Liang, Li-Jian
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (03) : 1025 - 1029